Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

8th Eurasian Hematology Oncology Summit
D

How I Treat PV in 2021: JAKi in Symptomatic Disease, Anti-Clonal Activity of PegIFN-Alpha, Phlebotomy&ASA +/- Ropeg-IFN Alpha-2b for Low-PV

By 8th Eurasian Hematology Oncology Summit FEATURING Dominik Wolf
By 8th Eurasian Hematology Oncology Summit FEATURING Dominik Wolf
106 views
May 13, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip
8th Eurasian Hematology Oncology Summit
14:53

Maintenance Therapy in AML: Overview of Outcomes and Future Approach…

8th Eurasian Hematology Oncology Summit

T. Kadia

153 views
13:09

Brentuximab Vedotin in HL: Evaluating the Clinical Data

8th Eurasian Hematology Oncology Summit

C. Gisselbrecht

27 views
10:10

The Role of MRD in AML: Navigating Testing Techniques & Prediction o…

8th Eurasian Hematology Oncology Summit

T. Kadia

279 views
19:17

Treating Myelofibrosis in 2021: What Are the Efficacy Data for Ruxol…

8th Eurasian Hematology Oncology Summit

H. Kathrin Al-Ali

171 views
19:08

2021 Efficacy Data Review in Relapsed CLL: BTK Inhibitors, Ven+/-Rit…

8th Eurasian Hematology Oncology Summit

S. O'Brien

145 views
16:00

Frontline Treatment of CLL: Surveying Outcomes With BTKi / BCL-2i Op…

8th Eurasian Hematology Oncology Summit

S. O'Brien

64 views
09:15

How I Treat ET in 2021: WHO True-ET, Thromboembolic/Bleeding Complic…

8th Eurasian Hematology Oncology Summit

D. Wolf

37 views
10:04

How I Treat PV in 2021: JAKi in Symptomatic Disease, Anti-Clonal Act…

8th Eurasian Hematology Oncology Summit

D. Wolf

106 views
14:23

Surveying the Data on DLBCL Treatments: RT Therapy in the PET Era, I…

8th Eurasian Hematology Oncology Summit

U. Vitolo

26 views
05:47

R/R DLBCL: Novel Strategies in 1L/2L Treatment

8th Eurasian Hematology Oncology Summit

U. Vitolo

142 views
06:03

Novel Strategies in 1/2L Large Cell Lymphoma: Navigating Treatment O…

8th Eurasian Hematology Oncology Summit

U. Vitolo

152 views
07:18

How Important Is Imaging (PET) for 1L Early Stage HL?

8th Eurasian Hematology Oncology Summit

C. Gisselbrecht

234 views
21:14

2021 Treatment Considerations for Follicular Lymphoma: Localized, Ad…

8th Eurasian Hematology Oncology Summit

G. Gaidano

202 views
12:00

Navigating Treatment Options for Newly Diagnosed ASCT-Eligible MM in…

8th Eurasian Hematology Oncology Summit

A. Maiolino

84 views
07:11

Survival Data for Newly Diagnosed ASCT-Ineligible MM: VRd vs. Rd, VM…

8th Eurasian Hematology Oncology Summit

A. Maiolino

13 views
21:36

CAR-T Cell Therapy for Multiple Myeloma

8th Eurasian Hematology Oncology Summit

E. Terpos

145 views
07:00

MRD in CLL: What Were the Changes and Issues Over the Years? Is This…

8th Eurasian Hematology Oncology Summit

R. Foa

216 views
17:18

2021 Updates on MRD in CLL: Chemoimmunotherapy vs. Targeted Approach…

8th Eurasian Hematology Oncology Summit

R. Foa

128 views
06:59

2021 Oral HMAs Efficacy Data in MDS: Decitabine + Cedazuridine for H…

8th Eurasian Hematology Oncology Summit

G. Garcia-Manero

81 views
15:42

2021 MDS Highlights: Luspatercept for Very Low-Intermediate Risk, Im…

8th Eurasian Hematology Oncology Summit

G. Garcia-Manero

45 views
20:55

2021 Lower Risk MDS Updates: RBC Transfusions, ESA in Anemia, Lenali…

8th Eurasian Hematology Oncology Summit

M. Mittelman

63 views
13:39

2021 Highlights on Higher Risk MDS: Can We Improve on Azacitidine? W…

8th Eurasian Hematology Oncology Summit

G. Garcia-Manero

251 views
25:12

2021 Updates on TFR in CML: What Are the Factors and Best Predictors…

8th Eurasian Hematology Oncology Summit

G. Saglio

12 views
21:28

How to Treat Newly Diagnosed AML in Unfit Patients: Pretreatment Tes…

8th Eurasian Hematology Oncology Summit

T. Kadia

146 views
08:17

Highlights on ETP-ALL: Recognition, Role of Allogeneic Transplant, C…

8th Eurasian Hematology Oncology Summit

S. Chiaretti

31 views
13:48

Updates on Ph-Like ALL: Genomic Background, Diagnosis, Outcomes, and…

8th Eurasian Hematology Oncology Summit

S. Chiaretti

108 views